Ortho Sales Partners Announces the Addition of Amanda Tracy as Senior Vice President of Business Development

Ortho Sales Partners, a global leader in orthopedic sales commercialization services, is pleased to announce the addition of Amanda Tracy as Senior Vice President of Business Development, further filling out its team of orthopedic and spine industry veterans. Ms. Tracy is a talented and well respected industry leader that has spent her career helping companies find solutions to complex problems.

Ms. Tracy is the third high-profile hire for Ortho Sales Partners in recent months and comes at an opportune time as the business continues to grow by assisting companies approach commercialization while mitigating the risks associated with such a big task. In recent years, there has been a huge shift in the market that reveals a reduction of surgeon influence with the adoption of new technologies. Ortho Sales Partners works with orthopedic and spinal device manufacturers to leverage their significant relationships with surgeons, distributors and national buying groups to help their clients realize faster growth while taking advantage of the economies of scale that have been implemented.

Ms. Tracy joins Ortho Sales Partners with 20 plus years of professional expertise. Notable is her most recent 10 years spent as the Vice President of Global Market Development for Musculoskeletal Clinical Regulatory Advisors, LLC ( MCRA).  Ms. Tracy established the business development function after joining MCRA during its early growth stage. Over tenure, Ms. Tracy played an instrumental role in expanding the firm’s portfolio services beyond its initial regulatory affairs service offering. Prior to MCRA, Ms. Tracy held senior product roles that included work for : Cyberonics ( LivaNova), Janssen Pharmaceutica (Johnson and Johnson ) and Eli Lilly and Company.

“I am thrilled to be able to join Ortho Sales Partners executive team at a true industry inflection point, when we can actualize the potential of novel approaches to technology sales execution and commercialization support.” said Ms. Tracy. “As a team, we will work to disrupt a fast-growing industry by building and launching innovative service products that extend Ortho Sales Partners’ current platform and build efficiencies for the industry.”

Maintaining her current geographical location in Southern California, Ms. Tracy will focus on accelerating Ortho Sales Partners innovative line of service offerings to support manufacturers, surgeons, distributors and investors alike. Ms. Tracy will also be representing the brands The De Angelis Group, Surg.io, OrthoExpress and OrthoSpineDistributors.com.

“We are thrilled to bring someone aboard with the pedigree and expertise of Amanda Tracy. We have had the pleasure of knowing her for more than 10 years and have seen first-hand the incremental value she brings to her employers and clients” said Josh Sandberg President, Ortho Sales Partners.  “This hire is another example of our commitment to offering our clients the best possible strategies and outcomes.”

Medrobotics® Corporation Flex® Robotic System Receives Best New Product Award at 2017 Edison Awards

May 01, 2017

RAYNHAM, Mass.–(BUSINESS WIRE)–Medrobotics Corp., a medical products company, announced today that its Flex®Robotic System received a Best New Product Award at the 2017 Edison Awards™. The Company’s rich history of innovation was recognized with a Bronze Award in the Surgical Tools category.

The Edison Awards™ is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation. The competition is open to progressive organizations across the globe. Award winners represent “game changing” products and services, as well as excellence and leadership in innovation. This year, more than 3,000 companies submitted applications. The winners were chosen as the “best of the best” by a panel comprised of individuals selected from the world’s top senior business executives, academics, and innovation professionals.

“Medrobotics is pleased the Flex® Robotic System has received this new recognition for its unique capabilities,” said Samuel Straface, Ph.D., President and CEO of Medrobotics. “Our products overcome the limits of traditional line-of-sight surgical technologies. Surgeons are now able to access difficult to reach anatomy through a single, small entry point and treat patients who might otherwise have required an open surgical procedure.”

Medrobotics’ Flex® Robotic System was designed to provide an affordable, easy-to-use robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to the broadest number of patients. Minimally invasive surgery has demonstrated advantages for patients and providers, such as shorter hospital stays and faster recovery times.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately funded medical device company headquartered in Raynham, Massachusetts. It manufactures and markets the Flex® Robotic System, the world’s first robotic surgical platform with a steerable and shapeable robotic scope. The Flex® Robotic System offers surgeons the unique ability to navigate complex anatomy through a single, small entry point and operate in hard-to-reach anatomical locations that might otherwise be inaccessible with straight, rigid surgical tools. The Company’s vision is to provide more patients with access to minimally invasive surgery. Medrobotics received FDA clearance for the Flex® Robotic System in July 2015, and the CE mark in March 2014.

Contacts

Medrobotics Corp.
Kevin Knight, 214-732-9392